LIAN Archives

ABOUT US

Business Headline is a digital news publication that covers a wide range of topics from India and around the world. We focuses on bringing our readers the latest news related to business, with a particular emphasis on the Global Market . Business Headline keeps its readers updated with all the latest news related to Business, Markets, Technology, Entertainment and Sports.

Tag: LIAN

LianBio Announces Results from Phase 3 EXPLORER-CN Trial of Mavacamten Presented at the European Society of Cardiology Congress and Simultaneous Publication in JAMA Cardiology

LianBio Reports Second Quarter 2023 Financial Results and Provides Corporate Update

LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis

LianBio Partner NANOBIOTIX Enters into License Agreement with Janssen for Radioenhancer NBTXR3, with LianBio Retaining Development and Commercialization Rights in Greater China, South Korea, Singapore and Thailand

LianBio Announces Phase 3 EXPLORER-CN Data Accepted for Late-Breaking Presentation at the European Society of Cardiology Congress 2023

LianBio Announces Clinical Supply Agreement with AstraZeneca in China to Evaluate BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR Mutations

LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in Singapore

LianBio Completes Enrollment in Pivotal Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis

LianBio Announces Topline Results from Phase 2a Proof of Concept Trial Evaluating Infigratinib in Patients with Gastric Cancer & Receipt of Breakthrough Therapy Designation in China

LianBio to Participate in Upcoming Investor Conferences

ABOUT US

FOLLOW US